arrow
M

Massimo Grimaldi

general regional hospital f miulli
H指数:22
被引数:2,729

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Contemporary invasive management and in-hospital outcomes of acute myocardial infarction in patients with active or prior cancer: insights from the EYESHOT-2 registry

当代对活动性或既往癌症患者急性心肌梗死进行侵入性管理及院内结局:EYESHOT-2注册研究的启示

2026-09-170
PRE
Multicentre experience with the variable-loop circular catheter pulsed-field ablation system for atrial fibrillation ablation

多中心应用可变环状环形导管脉冲场消融系统进行房颤消融的经验

2026-09-160
OAAI
Fulminant pheochromocytoma crisis triggered by glucocorticoids: ultra-early adrenalectomy under ECMELLA support

由糖皮质激素触发的爆发性嗜铬细胞瘤危象:在ECMELLA支持下的超早期肾上腺切除术

2026-08-280
OA
SGLT2 Inhibitors in Elderly Patients: Clinical Perspectives from Metabolic and Cardiorenal Protection to Implementation

老年患者的SGLT2抑制剂: 从代谢和心肾保护到实施的临床观点

2026-06-170
OA
Doming Volume in Mitral Valve Prolapse: Pathophysiology, Imaging Implications and Clinical Relevance

二尖瓣脱垂中的圆顶容积:病理生理学、影像学意义及临床相关性

2026-04-290
PRE
Effectiveness of AF Pulsed Field Ablation With a Variable Loop Circular Catheter: 12-Month VARIPURE Results

可变环状导管进行AF脉冲场消融的有效性:12个月VARIPURE研究结果

2026-04-110
OA
Multimodality Imaging in Apical Hypertrophic Cardiomyopathy: Can Echocardiography Learn from Cardiac Magnetic Resonance?

心尖部肥厚型心肌病中的多模态成像:超声心动图能否借鉴心脏磁共振?

2026-03-030
OAAI
Risk Stratification Tools in Acute Heart Failure and Their Roles in Personalized Follow-Up

急性心力衰竭中的风险分层工具及其在个性化随访中的作用

2025-12-190
OAAI
Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF

Finerenone:将MRAs的预后获益扩展至近期住院及症状更明显的HFpEF患者

2025-12-100
OAAI
SGLT2-is in Acute Heart Failure

SGLT2抑制剂在急性心力衰竭中的应用

2025-11-030
OAAI
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore

免疫疗法长期心血管毒性:不容忽视的重要性

2025-09-210
OAAI
Colchicine and Atherosclerotic Coronary Artery Disease: An Updated Review

秋水仙碱和动脉粥样硬化性冠状动脉疾病:一项更新综述

2025-09-110
OA